Adrien Dumoulin-Smith | White & Case LLP International Law Firm, Global Law Practice

Adrien Dumoulin-Smith

Associate, London

T +44 20 7532 1219

T +44 7734 001748 (mobile)

E [email protected]

in LinkedIn profile

Overview

Adrien Dumoulin-Smith is an associate in the Firm's Capital Markets Group in London. His practice involves representing investment banks and companies on a range of cross-border capital markets transactions, including SEC registered public offerings, Rule 144A/Reg S offerings and other public and private financings.

Bars and Courts

  • District of Columbia Bar

Education

  • MEL, Sciences Po, Ecole de Droit
  • JD, Duke University School of Law
  • MPP, University of Cambridge
  • BS, Cornell University, ILR School

Languages

  • English
  • French

Experience

ASELSAN, SPO, June 2018

Represented an underwriters' syndicate including Ak Yatırım Menkul Değerler A.Ş., İş Yatırım Menkul Değerler A.Ş., Garanti Yatırım Menkul Kıymetler A.Ş., Vakıf Yatırım Menkul Değerler A.Ş., Yapı Kredi Yatırım Menkul Değerler A.Ş., Ziraat Yatırım Menkul Değerler A.Ş. on the secondary public offering on Borsa Istanbul of Aselsan Elektronik Sanayi ve Ticaret A.Ş., a leading Turkish high-technology defense and security company, and a leading R&D house, for aggregate proceeds of TL 2,989,000,000 (approximately USD 653,500,015).

Medigene AG, PIPE, May 2018

Represented Guggenheim Securities, LLC and Baader Bank AG as bookrunners and Bryan Garnier & Co. as lead manager in the issuance and sale of 2,230,000 new shares from authorized capital of Medigene AG, a publicly listed biotechnology company developing highly innovative immunotherapies to target various forms and stages of cancer. The transaction also included a Secondary Share Sale by QVT Associates GP, LLC and affiliates of 1,105,490 existing shares. The total transaction value amounted to over €48 million and raised €32.3 million in gross proceeds for Medigene AG.

BerGenBio ASA, PIPE, April 2018

Represented Guggenheim Securities and Arctic Securities as joint-lead placement agents and bookrunners in the private placement of 4,629,245 new shares by BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors as a potential cornerstone of combination cancer therapy in NSCLC, AML/MDS, TNBC and melanoma. The private placement raised NOK 187.5 million (equivalent to approximately US$24 million) in gross proceeds for to fund the ongoing clinical development of pipeline candidates, strengthen working capital and general corporate purposes.

Novafives, High Yield, April 2018

Represented J.P. Morgan and BNP Paribas as Joint Global Coordinators on the offering of €325,000,000 5.00% Fixed Rate Senior Secured Notes due 2025 and €275,000,000 Floating Rate Senior Secured Notes due 2025 by Novafives, a leading global engineering services company based in France.

Bilibili Inc., IPO, April 2017

Represented Deutsche Bank Trust Company Americas as depositary on the offering of 42,000,000 American depositary shares, each representing one Class Z Ordinary Share, as part of the $483,000,000 initial public offering of Bilibili Inc. on the Nasdaq Global Select Market.

OneSmart International Education Group Limited, IPO, April 2018

Represented Deutsche Bank Trust Company Americas as depositary on the offering of 16,300,000 American depositary shares representing 652,000,000 Class A Ordinary Shares as part of the $179,300,000 initial public offering on the NYSE of OneSmart International Edication Group Limited.

Jianpu Technology, IPO, Novermber 2017

Represented Deutsche Bank Trust Company Americas as depositary on the offering of 22,500,000 American depositary shares as part of the $180,000,000 initial public offering on the NYSE of Jianpu Technology Inc., a leading independent open platform for discovery and recommendation of financial products in China.

Four Seasons Education, IPO, November 2017

Represented Deutsche Bank Trust Company Americas as depositary on the offering of 9,200,000 American depositary shares as part of the $101 million initial public offering on the NYSE of Four Seasons Education (Cayman) Inc.